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part of my lab in that direction with 
work on human embryonic stem cells 
which, as we have come to learn, 
show aberrant epigenetic regulation. 
There is a lot to learn from this much 
needed human model.
What do you enjoy most about 
science? The challenge, the 
discovery, and the people. In this 
profession, one meets some of 
the brightest (and most eccentric) 
minds on Earth. Although I dislike 
airports and flying, I do enjoy the 
chance to see different cultures, 
experience science as it is done in 
other countries, and taste great food 
(I always enjoy myself once I am 
there). Through science, one has the 
chance to make a lasting positive 
contribution to our society and 
planet.
Are there any disappointments in 
science? For me, one of the biggest 
attractions to science is that it is 
inherently value-free. There is one 
truth that cannot be changed by 
culture, history, and politics. But I no 
longer think that science is devoid of 
politics. Science itself is objective, 
but the practice of it is about people, 
personalities, and perceptions of 
what is important. We see this in 
the way grants are awarded, papers 
published, and policies established 
by the government. I see great 
ideas that are not given a chance at 
being tested because of diminishing 
resources; or great ideas not finding 
an appropriate place in the literature 
because of a general unwillingness 
to take risks on very imaginative 
thinking. Perhaps there is no way 
around this, especially with the 
current crisis in grant funding. Both 
junior and seasoned investigators 
spend a lot of time writing grants to 
keep their laboratories alive when 
their time would be more productively 
spent on experiments.
Any career advice for someone 
just starting their own lab? Stay 
at the bench for as long as possible, 
because it is more rewarding to 
do experiments than to exercise 
your administrative skills in the 
office. Nowadays, I am more coach, 
cheerleader, and psychologist than 
experimentalist — sadly. The people 
you hire are your greatest assets — 
choose and treat them well. Hire 
people with complementary skills and 
always try to keep a balance of talent 
and personalities in the lab. Over the 
years, I have come to value talent, 
work ethic, honesty, and collaborative 
spirit equally.
Are there gender differences in 
science? As someone who makes a 
living out of studying male and female 
differences, you might think that I am 
hardwired to think so! But I am not a 
big proponent of the idea that men 
and women inherently do science 
differently. Whatever difference there 
is, I am certain that there are many 
more differences among individuals 
and cultures than between the sexes. 
This I see in practice everyday. From 
what I can see in my own lab, there is 
not a significant ‘delta’ in work hours, 
talent, and commitment.
What emerging problems 
interest you most? There are so 
many problems I would work on 
now. If I were a student thinking 
about science, I might focus on 
environmental issues, energy, 
neurobiology, or cognitive science.  
I also think that the areas of  
genome–environment interactions 
and environmental toxicology 
(branches of epigenetics) will 
blossom in the coming years.
What would you like to see solved 
in the next 10 years? An end to 
global warming and pollution. I 
would also like to see better land 
stewardship and conservation. Do 
you think I’m unrealistic?
What advice would you give a 
student thinking about a career 
in academic science? You must 
love it — everything about it, from 
writing and speaking to thinking 
and doing. As with anything else in 
life, it is easier to love something 
when you are good at it. So find a 
problem that suits your talent and 
personal goals. Expect no immediate 
rewards (money, fame, prizes). If 
you are passionate about science, 
you will survive grant writing, paper 
rejections, and the long road to 
tenure. A life in science is one of the 
best there is.
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What is a tight junction? Tight 
junctions (TJs) are intercellular contacts 
that seal the space between the 
individual cells of an epithelial sheet 
so that they can collectively separate 
tissue compartments. The barrier 
is required to accomplish vectorial 
transport of material from one side of 
the compartment to the other and to 
limit paracellular entry of undesirables 
like toxins, antigens and microbes. 
The tight junction forms a continuous 
intercellular contact at the apical-most 
end of the lateral side of epithelial cells 
(Figure 1), above other specialized 
cell contacts like adherens and gap 
junctions and desmosomes. Its name 
derives from early transmission electron 
microscopy images showing membrane 
‘kiss points’ between adjacent cells 
where the outer membrane leaflets 
appeared to fuse. It is also called the 
occluding junction (OJ) and the zonula 
occludens (ZO). TJs do not just act as 
barriers but are also sites for vesicle 
targeting, cytoskeletal dynamics, 
signals controlling proliferation and 
transcription, and for defining cellular 
polarity between the functionally 
distinct apical and lateral membrane 
surfaces.
What are TJs made of? Compared 
with other junctions, TJs include a 
surprisingly large number of different 
proteins — at least 40. The actual 
barrier is formed by continuous 
adhesive strands of transmembrane 
proteins that interact to seal the 
paracellular space (Figure 1). These 
transmembrane proteins are called 
claudins and form the hallmark network 
of interconnected strands revealed 
by freeze–fracture EM. Many different 
claudins are often expressed in a single 
cell and their expression profiles create 
the variations in barrier properties 
observed among different tissues. 
Other adhesion proteins collect in 
the strands but their function remains 
unclear; these include tricellulin (which 
tends to concentrate where three 
cells come together), its homolog 
occludin and an immunoglobulin 
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transmembrane proteins are attached 
to a network of multi-PDZ proteins 
(including ZO-1, ZO-2, ZO-3, MAGI-1, 
PatJ, PALS1 and MUPP1), which is 
thought to cluster the barrier-forming 
proteins and provide redundant 
attachments to the actin cytoskeleton. 
Actin dynamics appear to be the key 
to junction assembly as well as to the 
physiological and pathological control 
of the barrier. 
How are TJs formed? This remains 
an active area of research. Assembly 
occurs downstream of signals initiated 
by other cell–cell adhesion complexes. 
Current evidence suggests a cascade 
initiated by intercellular adhesion 
between nectins, which, through 
several cytoplasmic proteins, recruit 
cadherin, which in turn, through 
other cytoplasmic linkers, determines 
the location of claudins. Proteins 
controlling actin dynamics (like 
Cdc42, RhoA, Rac, Rich1, GEF-H1, 
TUBA, cortactin and N-WASP) are 
also required, as are several kinase 
signalling pathways. The evolutionarily 
conserved polarity proteins (Par3, 
Par6 and aPKC) are also concentrated 
at the TJ and are required for TJ 
assembly and establishment of 
apical-basolateral cell polarity, in part 
through controlling actin dynamics. 
The TJ is intimately connected to and 
dependent on the cadherin-based 
adherens junction, and in endothelial 
cells the two often merge. 
What gets through the TJ? Although 
an oversimplification, it is useful to 
think of passage through the TJ barrier 
comprising two components — 
physiological pores and pathological 
breaks. All epithelial TJs have a 
system of small 8 Å diameter pores 
that varies among cell types in ionic 
charge selectivity and in porosity, i.e. 
the apparent number of pores. The 
mechanism controlling overall porosity 
is unclear, but it is known that ionic 
charge preference is controlled by 
claudins through electrostatic effects 
of fixed charges on their extracellular 
domains. The claudins form the pores 
or at least line them. Of those studied, 
each claudin has a characteristic 
influence on the permeability for small 
cations and anions. Current research 
attempts to draw parallels between the 
nascent field of TJ pores and the well-
established field of transmembrane 
ion channels. However, the TJ pore 
is structurally entirely different and 
is formed by repeating contacts of 
many proteins across the extracellular 
space as opposed to a few subunits 
perforating the bilayer. At this point we 
know painfully little about the structure 
of the TJ pore.
The passage of material larger than 
8 Å through the TJ shows no size or 
charge selectivity. Flux through this 
pathway is normally quite limited, 
leading to speculation that this 
pathway represents a pathological 
break between cells. Such breaks can 
arise in response to proinflammatory 
factors like interferon-γ and tumor 
necrosis factor-α (among others), 
which induce RhoA- and  
myosin-dependent endocytosis of 
TJ membranes and cytoskeletal 
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Figure 1. The tight junction barrier is formed by continuous rows of claudin proteins which ring 
the apical end of the cell. Different claudin gene products, depicted in different colors, assem-
ble in the barrier and create paracellular pores through their extracellular contacts (shown on 
the left). Claudin, and other types of strand proteins, are attached to multi-PDZ proteins and 
the actin cytoskeleton (right). Many other functional classes of proteins are found at TJs.contraction. There would be great 
benefit to understanding the control 
of TJ integrity since its breakdown 
enhances tissue damage by allowing 
entry of proinflammatory bacterial cell 
wall products, antigens and microbes.
When did TJs arise in evolution? 
Although a paracellular barrier of 
some description is a hallmark of 
all metazoans, the TJ appears to be 
specific for vertebrates. Invertebrates 
do have a related barrier called 
the septate junction, but, while in 
vertebrates, the TJ is more apical 
than the cadherin-based adherens 
junction, in invertebrates, the 
order is reversed with the septate 
junction being basal to the adherens 
junction. Whereas the TJ contacts 
appear in EM images to occlude the 
intracellular space, the intercellular 
septate contact is widely spaced 
and spanned by a ladder-like series 
of septa. Some of the cytoplasmic 
proteins are homologous, for example 
ZO-1 in vertebrates is the homolog 
of polychetoid in flies. Knockdown of 
one of the three claudin-like proteins 
found in the nematode Caenorhabditis 
elegans causes leakiness of the gut 
epithelium. Analogous barrier defects 
follow deletions of the Drosophila 
claudins, Sinuous and Megatrachea, 
which are located at septate junctions. 
Interestingly, the phenotypes of 
sinuous and megatrachea mutants 
also reveal a clear role for these 
claudins in developmental signaling 
and epithelial morphogenesis; 
evidence for this role for vertebrate 
claudins is pending. Finally, there is an 
intriguing structural similarity between 
the proteins found at the TJ and at 
synapses, suggesting a possible 
evolutionary connection between 
these functionally distinct cell 
contacts. For example, a PDZ domain 
interaction mediates binding at TJs 
of claudin to ZO-1 and in synapses of 
the AMPA receptor regulatory subunit 
(claudin homolog) to PSD-95 (ZO-1 
homolog). Both TJs and synapses are 
also hotspots for vesicle targeting.
Are TJs associated with diseases? 
When the TJ barrier fails, material can 
cross the epithelia in an unregulated 
fashion. Transepithelial absorption 
and secretion stop and antigens 
and microbes can breach the 
barrier. Almost anything that alters 
cell metabolism (toxic, metabolic, 
neoplastic or immune-based insults) 
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Wnt–β-catenin 
signaling 
Ken M. Cadigan
Wnts are a family of extracellular 
cell–cell signaling molecules which 
act in a wide range of developmental 
processes in metazoans; the 
name derives from the Drosophila 
gene Wingless, and the related 
mammalian oncogene Int-1.  
No-one knows for sure when the 
first Wnt evolved, but the existence 
of fourteen Wnt genes in the sea 
anemone Nematostella vectensis — 
by comparison, there are seven Wnts 
in Drosophila, five in Caenorhabditis 
elegans and nineteen in mice and 
humans — indicates that this gene 
family had already evolved and 
diversified more than 600 million 
years ago. Wnts are proteins defined 
by a conserved primary sequence 
that includes twenty-one specifically 
spaced cysteines. The expression 
pattern of the sea anemone Wnts 
suggests that they form a ‘Wnt-
code’ that specifies its basic body 
plan and recent functional studies 
indicate that Wnts are required 
for primary and axial patterning 
in several cnidarian species. For 
the metazoan species that have 
been exploited by developmental 
biologists for their ease of genetic 
analysis, such as flies, worms and 
mice, there is abundant evidence 
that many developmental decisions 
are controlled by Wnts, from 
gastrulation and early pattern 
formation to organogenesis. 
Although Wnts are known to 
influence cell behavior through 
several different signaling pathways, 
many act by regulating the stability 
and subcellular localization of 
β- catenin. This intensively studied 
signal cascade is known as the 
Wnt–β-catenin pathway, the focus  
of this primer.
While the Wnt–β-catenin 
pathway is often thought of as a 
major signaling pathway in animal 
development, it also plays important 
roles in stem cell maintenance 
in regenerating tissues such 
as intestinal epithelia and hair 
follicles. Wnt–β-catenin signaling 
Primerwill break the barrier, making the TJ a frequent contributor to a vast 
range of pathologies of blood vessels 
and epithelial organs. Since most of 
these insults have pleotropic cellular 
effects, it is difficult to envision 
therapies that could target specific TJ 
components or functions. In contrast, 
some assaults on the barrier are quite 
specific. For example, house dust 
mites excrete a fecal protease that 
cleaves occludin and claudin, loosens 
the barrier and in theory allows 
allergens to cross the airway and skin 
epithelia. Similarly, some types of 
allergenic pollen produce a protease 
which cleaves occludin, enhancing 
allergen entry. Specific claudins are 
receptors for a cytotoxic diarrhea-
inducing enterotoxin produced by 
Clostridium perfringens and other 
claudins are co-receptors required for 
hepatitis C virus to enter cells.
The growing list of diseases caused 
by mutations in the genes encoding 
TJ proteins has provided significant 
insight into how the TJ works. For 
example, claudins 16 and 19 form 
cation-selective pores and are located 
in a segment of the kidney tubule 
where Mg2+ ions return to the body 
by passing through the TJ. Mutations 
in either protein are associated with 
a failure to reabsorb Mg2+, leading to 
low serum Mg2+ levels and resultant 
weakness and seizures. Loss of ion 
selectivity may also explain why 
claudin-14 mutations lead to deafness. 
Mutations in PMP-22, a claudin 
which seals myelin, lead to peripheral 
neuropathies through an unknown 
mechanism. Hopefully our increasing 
knowledge of TJ structure will lead 
to specific therapies to preserve or 
restore integrity of the barrier. 
Can we manipulate TJs to enhance 
drug delivery? In principle it might 
be desirable to open TJs in order to 
enhance drug delivery across epithelia 
like the gut and airway surfaces or 
across blood vessels like the blood–
brain barrier. Manipulation of the 
barrier may be required for the delivery 
of emerging therapeutic agents based 
on peptides, proteins and DNA. 
Despite wide interest and research, 
however, no agents have yet reached 
clinical application. Early efforts 
employed non-specific attacks on 
general signaling pathways that led to 
cells being pulled apart or alternatively 
used detergents to disrupt epithelial 
integrity. More recent approaches specifically target the intercellular 
interactions of claudins or occludin. 
Given the role of TJs in limiting drug 
delivery, there is a lot of creative 
energy applied to this problem; 
however, we will have to wait to see 
whether it’s a good idea to break the 
barrier even transiently. 
Is there a link between TJs and 
cancer? As a rule, cells use every 
point of cell–cell and cell–substrate 
contact to transfer information. 
Although we do not yet know 
what information the cell receives 
at TJs, the importance of TJs for 
differentiation and proliferation is 
suggested by the frequent alteration 
in claudin profiles seen in specific 
cancers. During 2007 alone there 
were >60 publications on PubMed 
using different claudins to classify 
and even to prognosticate outcome in 
various human carcinomas. Beyond 
these correlations, there are a few 
papers that report the manipulations 
of claudin levels in human cancer 
cell lines and show a correlation with 
metastatic potential when injected 
into mice. A link to Wnt signaling has 
also been implicated. The massive 
overexpression of specific claudins 
in specific cancers has led to several 
proof-of-principle studies targeting 
those claudins for chemotherapy. 
Specifically, in mouse models, the 
previously mentioned C. perfringens 
toxin will effectively eliminate human 
ovarian and pancreatic cancers, 
which overexpress the toxin receptors 
claudins 3 and 4. However, much 
remains to be learnt before TJ 
signaling can be targeted for cancer 
therapy.
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